BG40318A3 - Method for preparing imunoglobuline derivatives of vindezine - Google Patents

Method for preparing imunoglobuline derivatives of vindezine

Info

Publication number
BG40318A3
BG40318A3 BG054907A BG5490782A BG40318A3 BG 40318 A3 BG40318 A3 BG 40318A3 BG 054907 A BG054907 A BG 054907A BG 5490782 A BG5490782 A BG 5490782A BG 40318 A3 BG40318 A3 BG 40318A3
Authority
BG
Bulgaria
Prior art keywords
derivatives
preparing
imunoglobuline
vindezine
vindesine
Prior art date
Application number
BG054907A
Other languages
Bulgarian (bg)
English (en)
Inventor
George Rowland
Robin Somminds
Original Assignee
Lilly Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Limited filed Critical Lilly Industries Limited
Publication of BG40318A3 publication Critical patent/BG40318A3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6805—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG054907A 1981-01-12 1982-01-08 Method for preparing imunoglobuline derivatives of vindezine BG40318A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8100847 1981-01-12

Publications (1)

Publication Number Publication Date
BG40318A3 true BG40318A3 (en) 1986-11-14

Family

ID=10518931

Family Applications (1)

Application Number Title Priority Date Filing Date
BG054907A BG40318A3 (en) 1981-01-12 1982-01-08 Method for preparing imunoglobuline derivatives of vindezine

Country Status (27)

Country Link
EP (1) EP0056322B1 (de)
JP (1) JPS57136529A (de)
KR (1) KR860001149B1 (de)
AT (1) ATE16603T1 (de)
AU (1) AU549495B2 (de)
BG (1) BG40318A3 (de)
CA (1) CA1180660A (de)
CS (1) CS235525B2 (de)
DD (1) DD201447A5 (de)
DE (1) DE3267474D1 (de)
DK (1) DK5982A (de)
EG (1) EG15599A (de)
ES (1) ES8304149A1 (de)
FI (1) FI820020L (de)
GB (1) GB2090837B (de)
GR (1) GR75182B (de)
HU (1) HU186025B (de)
IE (1) IE52239B1 (de)
IL (1) IL64722A (de)
MX (1) MX7215E (de)
NZ (1) NZ199421A (de)
PH (1) PH18031A (de)
PL (1) PL128529B1 (de)
PT (1) PT74252B (de)
RO (1) RO82758B (de)
SU (1) SU1069628A3 (de)
ZA (1) ZA82122B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639456A (en) * 1980-06-10 1987-01-27 Omnichem S.A. Vinblastin-23-oyl amino acid derivatives
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates
EP0121388B1 (de) * 1983-03-30 1990-06-13 Lilly Industries Limited Immunoglobulinkonjugate
US4596676A (en) * 1983-03-30 1986-06-24 Lilly Industries Limited Bifunctional ester derivatives of 4-desacetyl indole-dihydroindole alkaloids
EP0124502B1 (de) * 1983-04-29 1991-06-12 OMNICHEM Société anonyme Konjugierte Vinblastin-Verbindungen und ihre Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
GB2148299B (en) * 1983-09-01 1988-01-06 Hybritech Inc Antibody compositions of therapeutic agents having an extended serum half-life
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
US4667030A (en) * 1985-06-17 1987-05-19 Eli Lilly And Company Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids
FI860456A7 (fi) * 1985-07-16 1987-01-17 Huhtamaeki Oy Laeaeketehdas Le Bis-indolalkaloiders proteinkonjugat, bis-indolalkaloider, deras framstaellning och anvaendning.
EP0232693A3 (de) * 1985-12-16 1988-04-06 La Region Wallonne Konjugate des Vinblastins und seiner Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4801688A (en) * 1986-05-27 1989-01-31 Eli Lilly And Company Hydrazone immunoglobulin conjugates
ZA873600B (en) * 1986-05-27 1988-12-28 Lilly Co Eli Immunoglobulin conjugates
FR2626882B1 (fr) * 1988-02-08 1991-11-08 Ire Celltarg Sa Conjugues de derives de vinca comportant une chaine detergente en position c-3
US5028697A (en) * 1988-08-08 1991-07-02 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
US5006652A (en) * 1988-08-08 1991-04-09 Eli Lilly And Company Intermediates for antibody-vinca drug conjugates
US5094849A (en) * 1988-08-08 1992-03-10 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers
US5144012A (en) * 1988-08-08 1992-09-01 Eli Lilly And Company Cytotoxic drug conjugates
US5043340A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Derivatives of 4-desacetyl VLB C-3 carboxhydrazide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2456224A1 (de) * 1974-11-28 1976-08-12 Karl Dr Med Theurer Verwendung von nativen antikoerpern oder von antikoerper-fragmenten mit kovalent gebundenen oder konjugierten zytostatisch und/bzw. oder zytotoxisch wirkenden substanzen fuer die krebstherapie
GB1446536A (en) * 1975-02-21 1976-08-18 Yeda Res & Dev Pharmaceutically active compositions
FR2349335A1 (fr) * 1976-04-28 1977-11-25 Inst Int Pathologie Cellulaire Complexes d'alcaloides bis-indoliques du type vinblastine avec la tubuline, leur procede d'obtention et leur utilisation
EP0000938B1 (de) * 1977-08-22 1984-10-17 National Research Development Corporation Makromolekulare kovalente Konjugate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
FR2437213A1 (fr) * 1978-09-28 1980-04-25 Cm Ind Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation
JPS55136235A (en) * 1979-04-09 1980-10-23 Teijin Ltd Antitumor protein complex and its preparation

Also Published As

Publication number Publication date
JPS57136529A (en) 1982-08-23
CS235525B2 (en) 1985-05-15
SU1069628A3 (ru) 1984-01-23
KR830008684A (ko) 1983-12-12
PT74252B (en) 1983-08-24
ZA82122B (en) 1983-07-27
GB2090837A (en) 1982-07-21
EP0056322A1 (de) 1982-07-21
ATE16603T1 (de) 1985-12-15
KR860001149B1 (ko) 1986-08-18
ES508633A0 (es) 1983-02-16
IE820023L (en) 1982-07-12
GR75182B (de) 1984-07-13
MX7215E (es) 1988-01-08
DE3267474D1 (en) 1986-01-02
GB2090837B (en) 1984-07-18
FI820020A7 (fi) 1982-07-13
DK5982A (da) 1982-07-13
ES8304149A1 (es) 1983-02-16
CA1180660A (en) 1985-01-08
PH18031A (en) 1985-03-06
EP0056322B1 (de) 1985-11-21
DD201447A5 (de) 1983-07-20
IE52239B1 (en) 1987-08-19
IL64722A (en) 1985-07-31
IL64722A0 (en) 1982-03-31
FI820020L (fi) 1982-07-13
PL234695A1 (de) 1982-07-19
AU549495B2 (en) 1986-01-30
RO82758A (ro) 1984-01-14
EG15599A (en) 1986-06-30
NZ199421A (en) 1984-08-24
RO82758B (ro) 1984-01-30
AU7927482A (en) 1982-07-22
HU186025B (en) 1985-05-28
PL128529B1 (en) 1984-02-29
PT74252A (en) 1982-02-01

Similar Documents

Publication Publication Date Title
BG40654A3 (bg) Метод за получаване на циклоалкилтриазоли
BG40651A3 (en) Method for preparing (1- arylcyclobutyl) alkylamines
NL7904926A (nl) Werkwijze ter bereiding van synthesegas.
BG32851A3 (bg) Метод за получаване на 3,4,5,6-тетрахидро-2н- -1-бензоксецини
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG35330A3 (bg) Метод за получаване на 3-йодметилцефалоспорини
BG42185A3 (en) Method for preparing pyridylic compounds
EP0257778A3 (en) Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas
BG39976A3 (en) Method for preparing benzamides
DE3177276D1 (de) Monoklonale antikoerper.
BG30323A3 (en) Method for obtaining of n- dichloracethyl- 1, 2, 3, 4- tetrahydro- hinaldine
FI791143A7 (fi) Menetelmä histamiini-vasta-aineiden valmistamiseksi.
BG36932A3 (bg) Метод за получаване на 1-(3-хидрокси-4-метаксибензоил)-3- хидрокси-2-пиролидинон
BG40807A3 (en) Method for preparing n- phenylcarbamates
BG40803A3 (bg) Метод за получаване на арилциклобутилалкиламинови производни
BG36939A3 (bg) Метод за получаване на макролид
FI813666A7 (fi) Menetelmä 3,4-bis-substituoitujen 1,2,5- oksdiatsoli-2-oksidien valmistamiseksi.
BG38637A3 (en) Method for preparing 2- exo- hydroxy- 7- oxabicyclo [2, 2, 1] heptanes
BG36935A3 (en) Method for preparing benzodiazepine compounds
BG38940A3 (en) Method for preparing penicillanoyloxymethyl penicillanate- 1, 1- dioxide
FI823156A7 (fi) Menetelmä uusien polysyklisten polyatsaheterosyklien valmistamiseksi.
BG38337A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
BG35749A3 (bg) Метод за получаване на 20-дихидро-20,23-дидеокситидонолид
BG35895A3 (en) Method for preparing of n- substituted- 2- haloacetanilides
BG35896A3 (en) Method for preparing 3- halogen- 3- cephem compounds